Some investors asked questions to Santoku Technology on the interactive platform and noticed that your subsidiary Sande Yingtai's products have obtained sales orders in the field of semiconductor material testing. What is the current revenue share of this business? Are there any plans to further expand non-coal fields such as semiconductors, new energy materials, and biomedical testing in the future, or are there product verifications or customer breakthroughs in emerging testing fields such as semiconductor material testing and biomedical testing? Is the company considering setting up a higher value-added testing circuit through shareholding, mergers and acquisitions, or joint R&D? Santoku Technology replied that its subsidiary Sande Yingtai has sales orders in the field of semiconductor materials testing, but this business accounts for a relatively low share of the company's revenue. In 2025, the subsidiary's revenue was only 3.32% of that of the listed company. The company will continue to pay attention to technology trends in various industries and carefully evaluate related business expansion opportunities based on the accumulation and accumulation of its own technology, experience, resources, etc. Currently, there are no plans to participate in shares, mergers and acquisitions, or joint R&D.

Some investors asked questions to Santoku Technology on the interactive platform and noticed that your subsidiary Sande Yingtai's products have obtained sales orders in the field of semiconductor material testing. What is the current revenue share of this business? Are there any plans to further expand non-coal fields such as semiconductors, new energy materials, and biomedical testing in the future, or are there product verifications or customer breakthroughs in emerging testing fields such as semiconductor material testing and biomedical testing? Is the company considering setting up a higher value-added testing circuit through shareholding, mergers and acquisitions, or joint R&D? Santoku Technology replied that its subsidiary Sande Yingtai has sales orders in the field of semiconductor materials testing, but this business accounts for a relatively low share of the company's revenue. In 2025, the subsidiary's revenue was only 3.32% of that of the listed company. The company will continue to pay attention to technology trends in various industries and carefully evaluate related business expansion opportunities based on the accumulation and accumulation of its own technology, experience, resources, etc. Currently, there are no plans to participate in shares, mergers and acquisitions, or joint R&D.